Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Medpace Holdings, Inc. (MEDP) had Cost of Goods Sold of $182.15M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$708.45M |
|
$135.13M |
|
|
Cost of Goods Sold |
$182.15M |
$526.30M |
|
$555.18M |
|
$153.27M |
|
$3.56M |
|
$156.83M |
|
$156.83M |
|
$135.13M |
|
$135.13M |
|
$135.13M |
|
$135.13M |
|
$153.27M |
|
$160.40M |
|
28.85M |
|
29.53M |
|
$4.76 |
|
$4.65 |
|
| Balance Sheet Financials | |
$989.62M |
|
$131.06M |
|
$985.85M |
|
$1.98B |
|
$1.34B |
|
-- |
|
$172.65M |
|
$1.52B |
|
$459.07M |
|
$-236.74M |
|
$459.07M |
|
28.37M |
|
| Cash Flow Statement Financials | |
$713.22M |
|
$-31.14M |
|
$-860.39M |
|
$669.44M |
|
$497.05M |
|
$-172.39M |
|
$34.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.74 |
|
-- |
|
-- |
|
-- |
|
-- |
|
74.29% |
|
21.63% |
|
21.63% |
|
-- |
|
22.14% |
|
19.07% |
|
$681.87M |
|
-- |
|
-- |
|
-- |
|
0.36 |
|
-- |
|
1.76 |
|
51.08 |
|
29.44% |
|
-57.08% |
|
6.84% |
|
29.44% |
|
$16.18 |
|
$23.09 |
|
$24.15 |
|